As of January 22, 2025, Nautilus Biotechnology (NAUT) has a market cap of $0.25 billion USD. According to our data, Nautilus Biotechnology is ranked No.6875 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.25 B |
19.64%
|
Dec 31, 2024 | $0.21 B |
-43.81%
|
Dec 29, 2023 | $0.38 B |
66.11%
|
Dec 30, 2022 | $0.23 B |
-65.25%
|
Dec 31, 2021 | $0.65 B |
-52.26%
|
Dec 31, 2020 | $1.36 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
Bionano Genomics
BNGO
|
$25.94 M |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.73 B |
0.006 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Bruker
BRKR
|
$9.11 B |
0.000 M
|
USA
|
Danaher
DHR
|
$176.31 B |
-0.004 M
|
USA
|
Market Cap | = | NAUT Stock Price | * | NAUT Shares Outstanding |
= | $2.01 | * | 0.13 B | |
= | $0.25 B |